Your browser is no longer supported. Please, upgrade your browser.
NEW! Auto Refresh is now available in Screener. Let us know what you think. ×
XBI  SPDR S&P Biotech ETF daily Stock Chart
SPDR S&P Biotech ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week2.50%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month7.60%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter-3.15%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio- Perf Half Y-8.52%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year23.05%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range57.19 - 91.05 Perf YTD16.96%
Dividend0.46 P/FCF- EPS past 5Y- ROI- 52W High-20.43% Beta-
Dividend %0.63% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low26.68% ATR2.20
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)65.22 Volatility2.26% 3.23%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume0.41 Prev Close71.00
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume5.33M Price72.45
Recom- SMA203.79% SMA506.34% SMA200-3.66% Volume2,179,703 Change2.04%
Nov-24-15 09:35PM  Sarepta Rises 5.3%, Helping XBIs Small-Cap Stocks
09:35PM  Radius Falls by 11%, Hindering XBIs Mid-Cap Stock Performance
12:41PM  An Open Letter About Todays Market Environment 11-24-15
11:10AM  Does Recent Biotech Volatility Signal Tougher Times Ahead? at Forbes
08:15AM  Healthcare ETFs' Check Up Ahead of Higher Interest Rates
Nov-18-15 03:01PM  Amgen Rises by 2% as XBIs Large-Cap Stocks Rally
03:01PM  XBI Rises in Contrast to a Flat Market
Nov-17-15 09:04AM  Arena Rose 14% in XBIs Small-Cap Space
08:56AM  Biotech- Market leader facing breakout level
Nov-10-15 08:06AM  Dyax and Acadia Drove XBIs Mid-Cap Space
08:05AM  Vertex Reported Its 3Q15 Earnings: Stock Rose 5%
07:05AM  Buy Amgen's Healthy Dividend, Hold for Its Growth Prescription at TheStreet
Nov-09-15 01:37PM  Regulus Was Last Weeks Top Biotech Performer
08:03AM  Equal Weighting Works For This Industry ETF
Nov-07-15 12:07AM  AbbVie Topped XBIs Large-Cap Space
12:07AM  Moving Averages of XBIs Holdings Have Improved
Nov-06-15 01:02PM  Biotech: 'That Was Fun While It Lasted' at
11:10AM  Heres where youll find the next tech bubble at MarketWatch
Nov-05-15 03:42PM  Chinese economy stabilizing: Ulrich
03:39PM  30 minutes to close: Unusual volume
Nov-02-15 05:00PM  United Therapeutics Led the Biotechnology Subgroup for the Week +6.53%
07:34AM  3 Stocks to Buy Now in Biotech at Motley Fool
Nov-01-15 04:09PM  The Top 3 Biotech ETFs on the Market at Motley Fool
Oct-30-15 11:25AM  Amgen Reported Its 3Q15 Earnings: Stock Fell by 1.3%
11:24AM  XBI Fell the Most as the Small-Caps Took a Hit
08:19AM  Why biotech could be on the verge of a rebound
Oct-29-15 01:04AM  Opko Outperforms in XBIs Mid-Cap Space
Oct-28-15 03:12PM  Traders Get Adventurous With Leveraged Biotech ETFs
Oct-24-15 02:06PM  Baxalta in the XBI Top Ten Large Caps
02:04PM  The Bottom Ten Stocks of XBI Outperform on October 8
Oct-23-15 10:54AM  Talking Earnings Season With Estimize
01:05AM  Alnylam Up 2.0% on Phase 1 Initiation of OLE Study with ALT-AT3
Oct-19-15 06:57PM  Airlines ETF Zips Ahead; Tech ETFs Eye Amazon at Investor's Business Daily
09:10AM  Insight: Five Prime Therapeutics
09:05AM  Overview: Biotechnology companies Post Impressive Gains
Oct-16-15 05:56PM  Health-Care ETFs --- Are You With Us, Or Against Us? at
Oct-15-15 06:27PM  Biotech ETFs' Surge, Led By Small Caps; Banks Jump at Investor's Business Daily +7.15%
02:06PM  Alnylam and Intercept Drive IBBs Biotechnology Subgroup
Oct-12-15 12:07PM  XBIs Top Ten Large-Cap Stocks Remained Flat on October 8
12:07PM  Analyzing Juno Therapeutics Performance until September 2015
11:24AM  Five charts to start the week
09:30AM  Zacks Investment Ideas feature highlights: iShares Nasdaq Biotechnology, SPDR S&P Biotech ETF, ProShares Short S&P500, ProShares UltraShort S&P500 and ProShares UltraPro Short S&P500
Oct-09-15 12:35PM  Kite Pharma Traded above 100-Day Moving Average on October 8
12:34PM  SPDR S&P Biotech ETF (XBI) Had a Mixed Day on October 8
12:08PM  IMMU and ACRX Outperform in the Biotech Downdraft
12:08PM  IBB Underperform in the Mid-Cap Space on October 6
11:40AM  Juno Therapeutics (JUNO) Stock Could Lead the Way to a Biotech Bounce at TheStreet
10:45AM  7 Huge Mistakes Every ETF Investor Needs to Avoid
Oct-08-15 09:08AM  IBB and XBIs Top 10 Large-Cap Stocks Underperform
Oct-07-15 01:07PM  BioMarin Pharmaceutical Takes a Nosedive Last Week
12:50PM  Wednesday links: addicted to liquidity
10:55AM  Illumina Fell 10.6% on a Biotech Sell-Off
08:03AM  3 Large-Cap Biotech Stocks Whose Valuations Should Make You Skeptical at Motley Fool
Oct-05-15 11:45AM  Biotechs - Boom, Bust, Now Buy at Forbes
Oct-02-15 04:07PM  XBIs Top Ten Small-Cap Stocks Perform on Par with Large-Caps
04:07PM  ALNY and XON Drag Down Mid-Cap Stocks Last Week
02:53PM  Breaking Down Biotech ETFs With Leverage
Oct-01-15 02:26PM  Biotech: buy the dip?
10:22AM  Biotech: Out of the Ashes at
09:10AM  BioMarin Falls 16.81% in Week Ended September 25
08:55AM  Biotech ETFs Looking Attractive After Sell-Off
07:50AM  China Whacks the Caixin/Markit Survey - Try the Shells in a White Wine, Sausage Cream Sauce
12:06AM  Alkermes and Incyte Outperform in Large-Cap Space
Sep-30-15 11:57PM  Has The Biotech Stock Bubble Popped? at Forbes
02:25PM  XBIs Moving Averages: The Massive Plummet Last Week
02:25PM  Biotech Stocks Hammered Badly Last Week after Clinton Comment
02:09PM  Biotech: Will Valuation End the Carnage? at
07:45AM  Lets Play Dress Up - Try the Risotto di Limone & Gamberi (Lemon Risotto w/Shrimp)
Sep-29-15 02:50PM  Price controls on biotech do not work: Pro
12:09PM  XBIs Top Ten Small-Caps Outperform IBBs Top Ten Small-Caps
Sep-28-15 05:06PM  Opko Health Falls 7.7% in Week Ended September 11 -7.19%
04:55PM  Biotech fund posts worst single-day drop in 4 years at MarketWatch
02:04PM  Step away from biotechs, let dust settle: Pro
01:33PM  Drug Pricing Fears Erase Biotech Stock Gains for the Year at TheStreet
01:03PM  Good-Bye Biotech Bull, Hello Pain at
12:16PM  Ill at Ease with Biotech? Prescribing #1 Healthcare ETFs
11:58AM  Gilead Sciences: 'The Machine Marches Forward' at
11:30AM  Biotech Moves Into A Bear Market And This Record Streak Is About To End
11:05AM  Seattle Genetics: A Performance Overview
10:14AM  XBI Mid-Caps Outperform IBB Mid-Caps
07:30AM  Global Mkts on Sale (Again) - Try the Vellutata di Verdura
Sep-25-15 05:37PM  IBB biotech fund posts largest weekly drop in 7 years at MarketWatch -6.85%
Sep-24-15 01:33PM  Biotech stocks on track for biggest weekly decline in 4 years at MarketWatch
12:07PM  Kite Led Top Ten Stocks by Weight in XBIs Biotechnology Subgroup
12:07PM  Top Ten Stocks of XBI by Weight Outperform
10:39AM  Biotech: Two Charts That Scream Sell at
09:08AM  Advaxis Led the Bottom Ten Biotechnology Stocks by Market Cap
09:07AM  Amicus Drives Small-Cap Stocks
07:52AM  Dont dump biotechnology stocks yet, says chart guru Thomas Dorsey at MarketWatch
Sep-23-15 07:13PM  Biotech ETFs Lose Steam, Extend Week's Losses at Investor's Business Daily
02:53PM  Outrage over high drug costs unlikely to bring change any time soon at MarketWatch
01:52PM  Small-Cap Biotech ETF Rallies Amid Broad Losses at Investor's Business Daily
12:08PM  Seattle Genetics Leads XBI Mid-Cap Stocks
10:48AM  Traders Bet Against Hillary With Leveraged Biotech ETF
09:08AM  XBIs Biotechnology Stocks Rose Week of September 11
07:13AM  Kite Pharma and Juno Therapeutics Led Biotechnology Sector
Sep-22-15 01:55PM  Stocks Extend Sharp Losses on Oil Rout, Fed Hangover at TheStreet
12:59PM  Stocks Extend Losses on Oil Rout, Fed Hangover at TheStreet
12:36PM  Tuesday links: a bull market built on sand
11:13AM  Stocks Extend Losses on Oil Rout at TheStreet
The investment seeks to provide investment results that, before fees and expenses, correspond generally to the total return performance of an index derived from the biotechnology segment of a U.S. total market composite index. In seeking to track the performance of the S&P Biotechnology Select Industry Index (the "index"), the fund employs a sampling strategy. It generally invests substantially all, but at least 80%, of its total assets in the securities comprising the index. The index represents the biotechnology industry group of the S&P Total Market Index ("S&P TMI"). The fund is non-diversified.